Immune Checkpoint Profiling in Humanized Breast Cancer Mice Revealed Cell-Specific LAG-3/PD-1/TIM-3 Co-Expression and Elevated PD-1/TIM-3 Secretion
Christina Bruß(University Hospital Regensburg), Anja K. Wege(Cancer Research UK)
Cited by 19
Related Papers
Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy
|Cell Reports|2019|297
Humanized tumor mice—A new model to study and manipulate the immune response in advanced cancer therapy
|International Journal of Cancer|2011|105